The price of Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) shares last traded on Wall Street rose 5.24% to $2.01.
LXRX stock price is now 19.49% away from the 50-day moving average and 6.12% away from the 200-day moving average. The market capitalization of the company currently stands at $726.59M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $10, H.C. Wainwright recently initiated with Buy rating for Lexicon Pharmaceuticals Inc (NASDAQ: LXRX). On April 30, 2024, Leerink Partners recently initiated its ‘Outperform’ rating on the stock quoting a target price of $5, while ‘Jefferies’ rates the stock as ‘Hold’
In other news, COATS LONNEL, Former Affiliate bought 300,000 shares of the company’s stock on Aug 15 ’24. The stock was bought for $480,000 at an average price of $1.60. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 16 ’23, Chief Executive Officer COATS LONNEL bought 90,000 shares of the business’s stock. A total of $94,797 was incurred on buying the stock at an average price of $1.05. This leaves the insider owning 914,359 shares of the company worth $1.84 million. A total of 3.44% of the company’s stock is owned by insiders.
During the past 12 months, Lexicon Pharmaceuticals Inc has had a low of $0.92 and a high of $3.73. As of last week, the company has a debt-to-equity ratio of 0.44, a current ratio of 11.51, and a quick ratio of 11.49. The fifty day moving average price for LXRX is $1.6822 and a two-hundred day moving average price translates $1.89425 for the stock.
The latest earnings results from Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) was released for 2024-06-30. The net profit margin was -5509.34% and return on equity was -94.10% for LXRX. The company reported revenue of $1.65 million for the quarter, compared to $0.32 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 419.56 percent.
